Accelerate Diagnostics, Inc. filed for Chapter 11 bankruptcy on May 8, 2025, leading to its delisting from Nasdaq due to not meeting the minimum bid price and market value requirements, with trading expected to shift to the OTC market under symbol AXDXQ.